Pharmaspectra’s Global Meetings Coverage
Pharmaspectra’s Global Meetings Coverage
With medical literature, it’s not only important to access the information from the tens of thousands of global sources, but to understand the historical context as well.
The Crucial Role of Conference Papers in an Era of Hyperspecialization
Conference literature can be an important way to bridge the gap between different scientific specialties — and to broaden the general knowledge base of specialists READ MORE
What data tips the scale for a “go” decision among care providers?
At a high level, providers are concerned with two primary considerations: cost and quality. READ MORE
How to Optimize Your Medical Affairs Efforts: Share of Scientific Voice
Share of Scientific Voice is a relative measure of how frequently your drug or other therapeutic is mentioned in the biomedical discourse. There are no hard and fast rules for defining the domain but it should be broad enough to include treatment options a physician would consider. READ MORE
PHARMASPECTRA AND DOCTOR EVIDENCE TEAM UP TO COMBINE LEADING CONGRESS DATA WITH LEADING AI SEARCH TECHNOLOGY
POSTED...
Pharmaspectra’s Global Meetings Coverage
With medical literature, it’s not only important to access the information from the tens of thousands of global sources, but to understand the historical context as well.
READ MORE
PHARMASPECTRA ANNOUNCES INVESTMENT IN ITS FUTURE GROWTH PLAN
Pharmaspectra receives funding from private equity firm, Inflexion.
READ MORE
Identifying Predatory Journals
The rise of these predatory journals has largely been driven by the “publish or perish” dictum predominant in academia, where careers, promotions, and funding can depend on publishing research. To identify these problematic publications, look for these hallmarks
READ MORE
The Role of Medical Affairs in Healthcare
As healthcare has evolved, the ecosystem has become more complex. Today medical affairs is in a position to help facilitate the communication
READ MORE
When Real-World Evidence and Randomized Clinical Trials Disagree
The findings of real-world evidence studies sometimes contradicts the results of randomized clinical trials. This raises the question of how to reconcile the two.
READ MORE
Rethinking Journal Submissions
Where to Publish Drug Trial Results? Traditional Journal Rankings Fail to Deliver their Promised Impact
READ MORE
3 Flaws in the Journal Impact Factor
The JIF has come under growing criticism for its various shortcomings. These include its ineffectiveness as a tool for predicting an article's impact, the opaque methods used to calculate it, and its potential for misuse.
READ MORE
Measuring Journal Impact? Consider These Three Alternatives
While such impact scores have their merits for the authors themselves — whose paychecks, reputations, grants, and very careers notoriously depend on the journals they reach and the citations received in their wake — those types of quantitative metrics only tell half the story for Medical Affairs professionals
READ MORE
Conference Proceedings Key to Faster Dissemination of Findings
Getting published in a high-impact journal is no longer the only way to disseminate biomedical knowledge. Conference proceedings, posters, and the emerging practice of nanopublishing are changing the pace and volume of publications.
READ MORE
